Search Results - "MORSE, Michael"

Predissociation Measurements of Bond Dissociation Energies by Morse, Michael D

“…Conspectus A fundamental need in chemistry is understanding the chemical bond, for which the most quantitative measure is the bond dissociation energy (BDE)…”
Get full text

The future of felon disenfranchisement reform: Evidence from the campaign to restore voting rights in Florida by Morse, Michael

“…This Article offers an empirical account of felon disenfranchisement and legal financial obligations in the era of mass incarceration. It focuses on a 2018…”
Get full text

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians by Moris, Dimitrios, Palta, Manisha, Kim, Charles, Allen, Peter J., Morse, Michael A., Lidsky, Michael E.

“…Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and remains a fatal malignancy in the majority of patients. Approximately…”
Get full text

Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy by Morse, Michael A., Hochster, Howard, Benson, Al

“…Despite lengthening survival, death rates from metastatic colorectal cancer (CRC) remain unacceptably high, with a bright spot being the demonstration of…”
Get full text

The Role of Angiogenesis in Hepatocellular Carcinoma by Morse, Michael A, Sun, Weijing, Kim, Richard, He, Aiwu Ruth, Abada, Paolo B, Mynderse, Michelle, Finn, Richard S

“…Hepatocellular carcinoma (HCC) accounts for about 90% of all primary liver cancers and is the second leading cause of cancer-related deaths worldwide. The…”
Get full text

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial by Antonia, Scott J, Prof, López-Martin, José A, MD, Bendell, Johanna, MD, Ott, Patrick A, MD, Taylor, Matthew, MD, Eder, Joseph Paul, MD, Jäger, Dirk, MD, Pietanza, M Catherine, MD, Le, Dung T, MD, de Braud, Filippo, Prof, Morse, Michael A, Prof, Ascierto, Paolo A, MD, Horn, Leora, MD, Amin, Asim, MD, Pillai, Rathi N, MD, Evans, Jeffry, Prof, Chau, Ian, MD, Bono, Petri, MD, Atmaca, Akin, MD, Sharma, Padmanee, Prof, Harbison, Christopher T, PhD, Lin, Chen-Sheng, PhD, Christensen, Olaf, MD, Calvo, Emiliano, Dr

“…Summary Background Treatments for small-cell lung cancer (SCLC) after failure of platinum-based chemotherapy are limited. We assessed safety and activity of…”
Get full text

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer by Overman, Michael J, Lonardi, Sara, Wong, Ka Yeung Mark, Lenz, Heinz-Josef, Gelsomino, Fabio, Aglietta, Massimo, Morse, Michael A, Van Cutsem, Eric, McDermott, Ray, Hill, Andrew, Sawyer, Michael B, Hendlisz, Alain, Neyns, Bart, Svrcek, Magali, Moss, Rebecca A, Ledeine, Jean-Marie, Cao, Z Alexander, Kamble, Shital, Kopetz, Scott, André, Thierry

“…Purpose Nivolumab provides clinical benefit (objective response rate [ORR], 31%; 95% CI, 20.8 to 42.9; disease control rate, 69%; 12-month overall survival…”
Get full text

Chemical Bonding and Electronic Structure of the Early Transition Metal Borides: ScB, TiB, VB, YB, ZrB, NbB, LaB, HfB, TaB, and WB by Merriles, Dakota M, Nielson, Christopher, Tieu, Erick, Morse, Michael D

“…The predissociation thresholds of the early transition metal boride diatomics (MB, M = Sc, Ti, V, Y, Zr, Nb, La, Hf, Ta, W) have been measured using resonant…”
Get full text

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study by Overman, Michael J, McDermott, Ray, Leach, Joseph L, Lonardi, Sara, Lenz, Heinz-Josef, Morse, Michael A, Desai, Jayesh, Hill, Andrew, Axelson, Michael, Moss, Rebecca A, Goldberg, Monica V, Cao, Z Alexander, Ledeine, Jean-Marie, Maglinte, Gregory A, Kopetz, Scott, André, Thierry

“…Metastatic DNA mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer has a poor prognosis after treatment with…”
Get full text

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial by Sharma, Padmanee, Prof, Callahan, Margaret K, MD, Bono, Petri, MD, Kim, Joseph, MD, Spiliopoulou, Pavlina, MD, Calvo, Emiliano, MD, Pillai, Rathi N, MD, Ott, Patrick A, MD, de Braud, Filippo, Prof, Morse, Michael, Prof, Le, Dung T, MD, Jaeger, Dirk, MD, Chan, Emily, MD, Harbison, Chris, PhD, Lin, Chen-Sheng, PhD, Tschaika, Marina, MD, Azrilevich, Alex, PharmD, Rosenberg, Jonathan E, MD

“…Summary Background Few effective treatments exist for patients with advanced urothelial carcinoma that has progressed after platinum-based chemotherapy. We…”
Get full text

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells by Trapnell, Cole, Cacchiarelli, Davide, Grimsby, Jonna, Pokharel, Prapti, Li, Shuqiang, Morse, Michael, Lennon, Niall J, Livak, Kenneth J, Mikkelsen, Tarjei S, Rinn, John L

“…An algorithm uncovers transcriptome dynamics during differentiation by ordering RNA-Seq data from single cells. Defining the transcriptional dynamics of a…”
Get full text

Vaccine Therapies for Cancer: Then and Now by Morse, Michael A., Gwin, William R., Mitchell, Duane A.

“…There are strong biologic and preclinical rationales for the development of therapeutic cancer vaccines; however, the clinical translation of this treatment…”
Get full text

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results by Sharma, Padmanee, Siefker-Radtke, Arlene, de Braud, Filippo, Basso, Umberto, Calvo, Emiliano, Bono, Petri, Morse, Michael A, Ascierto, Paolo A, Lopez-Martin, Jose, Brossart, Peter, Rohrberg, Kristoffer, Mellado, Begoña, Fischer, Bruce S, Meadows-Shropshire, Stephanie, Abdel Saci, Callahan, Margaret K, Rosenberg, Jonathan

“…CheckMate 032 is an open-label, multicohort study that includes patients with unresectable locally advanced or metastatic urothelial carcinoma (mUC) treated…”
Get full text

CrN, CuB, and AuB: A Tale of Two Dissociation Limits by Merriles, Dakota M., Morse, Michael D.

“…Predissociation thresholds corresponding to dissociation at ground state separated atom limits (SALs) have been recorded in this group for more than 100 d- and…”
Get full text

Bond Dissociation Energies of Tungsten Molecules: WC, WSi, WS, WSe, and WCl by Sevy, Andrew, Huffaker, Robert F, Morse, Michael D

“…Resonant two-photon ionization spectroscopy was used to locate predissociation thresholds in WC, WSi, WS, WSe, and WCl, allowing bond dissociation energies to…”
Get full text

Venous Invasion in Pancreatic Neuroendocrine Tumors Is Independently Associated With Disease-free Survival and Overall Survival by Shi, Chanjuan, Chen, Wei, Davis, Richard, Morse, Michael A.

“…In this study, we evaluated venous invasion and its association with survival in patients with resected pancreatic neuroendocrine tumor (PanNET). Surgical…”
Get full text

Probing the Chemical Bond between Lanthanides and Carbon: CeC, PrC, NdC, LuC, and TmC2 by Merriles, Dakota M., London, Anthony, Tieu, Erick, Nielson, Christopher, Morse, Michael D.

“…Resonant two-photon ionization experiments have been conducted to probe the bond dissociation energy (BDE) of the lanthanide–carbon bond, allowing the BDEs of…”
Get full text

Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer by Morse, Michael A., Overman, Michael J., Hartman, Leighanne, Khoukaz, Taline, Brutcher, Edith, Lenz, Heinz‐Josef, Atasoy, Ajlan, Shangguan, Tong, Zhao, Huanyu, El‐Rayes, Bassel

“…Background Early detection and management of treatment‐related adverse events (TRAEs) in patients receiving immune checkpoint inhibitors may improve outcomes…”
Get full text

DC-CIK as a widely applicable cancer immunotherapy by Wang, Shuo, Wang, Xiaoli, Zhou, Xinna, Lyerly, Herbert Kim, Morse, Michael A, Ren, Jun

“…: Immunotherapy is now a standard treatment for many malignancies. Although immune checkpoint inhibition has demonstrated substantial efficacy by enhancing T…”
Get more information

Early Transition Metals Strengthen the B2 Bond in MB2 Complexes by Merriles, Dakota M, Tomchak, Kimberly H, Nielson, Christopher, Morse, Michael D

“…The bond dissociation energies of early transition metal diborides (M–B2, M = Sc, Ti, V, Y, Mo) have been measured by observation of the sharp onset of…”
Get full text